QuidelOrtho Corporation (QDEL)
Makes lab and diagnostic tests that detect diseases in blood and body fluids.
$16.73-0.01%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-26.7%
The outlook
QDEL is trading near the lower end of its 52-week range after a mixed performance against its moving averages. Analyst coverage shows a notably bullish average target sitting roughly 23% above the current price. Overall sentiment leans neutral, reflecting divergence between current price weakness and analyst expectations.
What’s behind the score
Price trendMixed vs its moving averages
52-week range27% of the way from its 52-week low to high
Price targetAvg target +23% vs current price
Analyst price target
~12-month · 4 analysts$20.50average target+22.5% vs now
Now $16.73
Low $12.00High $38.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.14B
52-wk high
$35.58
52-wk low
$9.92
50-day avg
$14.77
200-day avg
$21.07
Trailing P/E
—